Health workers attend to an Ebola patient at the Rwampara treatment Centre in Ituri, DR Congo, 18 June 2026.
Copyright © africanews
Last updated:
54 minutes ago
Democratic Republic Of Congo
They will begin next week in the DR Congo to see whether two antivirals can help reduce mortality in patients with the rare Bundibugyo strain of the virus.
Health workers attend to an Ebola patient at the Rwampara treatment Centre in Ituri, DR Congo, 18 June 2026.
Copyright © africanews
Last updated:
54 minutes ago
Democratic Republic Of Congo

Trials of two separate potential treatments to fight the deadly Ebola outbreak in the Democratic Republic of Congo are expected…

A first ray of hope for Ebola patients in the Democratic Republic of the Congo as the trial of two potential treatments for the…

The study comes as the DRC continues to battle a growing Ebola outbreak caused by the Bundibugyo strain, which has also spread…

The trial of two potential treatments for the Bundibugyo species of Ebola behind the deadly outbreak in the DR Congo began in the…

A clinical trial for two potential Ebola treatments, MBP134 and remdesivir, has commenced in DR Congo to combat the deadly…

A clinical trial for Ebola treatments targeting the current outbreak in the Democratic Republic of Congo has commenced, enrolling…